In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipients. (Q48247827)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

H de Jonge

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

K Verbeke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Y Vanrenterghem

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

D R J Kuypers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

13 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

414-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic monitoring of calcineurin inhibitors for the nephrologist

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Immunosuppression: evolution in practice and trends, 1994-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Pharmacokinetic principles of immunosuppressive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Transporter-Enzyme Interactions: Implications for Predicting Drug-Drug Interactions from In Vitro Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Mechanisms of clinically relevant drug interactions associated with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Drug-drug interactions with immunosuppressive agents: review of the in vitro functional assays and role of cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Drug Interactions Should Be Evaluated in Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Sex differences in CYP3A activity using intravenous and oral midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Midazolam is metabolized by at least three different cytochrome P450 enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Unmasking the dynamic interplay between efflux transporters and metabolic enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Effects of calcineurin inhibitors on sirolimus pharmacokinetics during staggered administration in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: a clinically relevant pharmacokinetic interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Sotrastaurin and tacrolimus coadministration: effects on pharmacokinetics and biomarker responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

The use and abuse of prescription medication to facilitate or enhance sexual behavior among adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Active drug transport of immunosuppressants: new insights for pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

In vitro effects of tacrolimus on human cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Studies on the Interactions between Drug and Estrogen. II. On the Inhibitory Effect of 29 Drugs Reported to Induce Gynecomastia on the Oxidation of Estradiol at C-2 or C-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Distribution of cyclosporin in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Pharmacokinetics and drug metabolism in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Association of genotypes of the CYP3A cluster with midazolam disposition in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

inferred from DOI database lookup

7 January 2021

based on heuristic

Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

inferred from DOI database lookup

7 January 2021

based on heuristic

CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.130

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2011.130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21753749%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference